magrolimab plus azacitidine in treatment-naïve aml
Published 3 years ago • 140 plays • Length 2:26Download video MP4
Download video MP3
Similar videos
-
0:44
predictors of poor response to azacitidine, venetoclax, and magrolimab in tp53-mutated aml
-
2:26
enhance-2: phase iii study of magrolimab plus azacitidine in untreated tp53-mutant aml
-
1:57
tolerability and efficacy of magrolimab plus azacitidine in tp53-mutated aml patients
-
1:31
advances in mds treatment: the promise of magrolimab plus azacitidine
-
1:35
enhance-2 and enhance-3: exploring magrolimab combinations in aml
-
5:07
kristin & benny: immunotherapy & acute lymphoblastic leukemia
-
4:54
imugene reports promising results in phase 1b trial for azer-cel in dlbcl
-
8:14
progress in the treatment of tp53 mutated aml
-
5:22
magrolimab azacitidine in mds and aml
-
2:43
magrolimab azacitidine in tp53-mutant aml
-
5:48
magrolimab in combination with azacitidine in untreated aml
-
6:26
magrolimab with azacitidine in patients with aml
-
2:50
magrolimab azacitidine in untreated higher-risk mds
-
1:12
hma in combination with venetoclax and magrolimab in the treatment of aml
-
1:59
depth of molecular response in patients with tp53m mds & aml treated with magrolimab and azacitidine
-
2:53
venetoclax and magrolimab for treatment of aml and mds
-
1:24
antibodies for the treatment of mds: magrolimab & sabatolimab
-
3:50
investigating the safety & efficacy of magrolimab, azacitidine & venetoclax in patients with aml
-
1:03
exploring the safety & efficacy of magrolimab plus oral decitabine/cedazuridine in mds
-
2:09
advances in targeted approaches for aml: magrolimab & pivekimab sunirine
-
2:41
immunotherapy in aml: azacitidine plus checkpoint inhibitors
-
1:46
tagraxofusp combined with azacitidine and venetoclax in the treatment of bpdcn and aml